TEANECK, NJ--(Marketwired - September 05, 2016) - The 10th Anniversary Pharma ChemOutsourcing show, slated to take place September 19-21, 2016 in Parsippany, NJ, will be the best-attended event in its ten year history. According to its President, Mark Alexay, the jump in attendance is due primarily to increasing numbers of exhibitors and innovator pharmaceutical company customers. The annual New Jersey event attracts pharmaceutical ingredient buyers and sellers from 30 countries.
The number of exhibitors from Japan, France and Germany, particularly, is on the rise. 60% are US-based. Innovator biopharmaceutical companies from the major hubs, San Francisco, Cambridge, New Jersey, Maryland, and San Diego, will be on hand.
"It's encouraging to witness the event grow with increasing numbers of suppliers of API development and manufacturing services turning up every year. They come to meet their pharma customers. We spend a lot of our time building close relationships with the pharmaceutical companies. They attend every year to meet their suppliers, and also, their peers. The globalizing supply chain of pharmaceutical ingredients has turned the show into a world event."
Alexay went on to add, "The pharmaceutical and chemical industries are healthy and productive. Lots of investment capital is flowing in to support the heavy R&D, especially among the legions of small biopharmaceutical companies our economy spawns. This shot of investor confidence in the sector is driving new drug discovery and development. It's no longer just Big Pharma."
Alexay continued, "The FDA has been approving 30-45 new medicines annually over the last 5 years. Between our academic research universities and major scientific breakthroughs, like the Human Genome Project, The United States is the leader in pharmaceutical innovation. I can't wait to see what medicines the next round of discoveries will yield!"
The inaugural ChemOutsourcing event took place in 2007. Originally a drug discovery and early clinical stage development chemistry sourcing trade show, it has evolved to now encompass commercial API manufacturing, clinical supply, and generics. Packaging, formulation and drug product will be added in 2017.
"In 2016," Alexay concluded, "pharmaceutical chemists and engineers from all the biopharmaceutical hotspots will be attending the show. Our hundreds of biopharmaceutical drug companies are the future of the industry and a source of economic growth. It's only going to get more exciting!"